Tevogen Bio enters $50M at-the-market equity sales agreement with A.G.P.

Tevogen Bio Holdings Inc.

Sales agreement allows issuance and sale of up to $50M of common stock from time to time.
Sales will be made through A.G.P./Alliance Global Partners as agent at market prices.
Offering conducted under effective shelf registration statement (File No. 333-288218).
Company pays agent a commission on gross proceeds and provides customary indemnification.
Company is not obligated to sell any shares and may terminate the agreement at any time.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.